PixCell Medical, an innovator of rapid hematology testing solutions at the point-of-care, has developed HemoScreen™, the only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared and CE-marked for point-of-care use. The portable, easy to use platform offers clinically proven lab-accurate readings of 20 standard blood count parameters within five minutes, with just one finger-prick of blood. This facilitates fast diagnostic results and data-driven disease management decisions. Leveraging a patented, disposable cartridge preloaded with all necessary reagents, the company's unique Viscoelastic Focusing technology and AI-powered machine vision, PixCell enables improved medical outcomes and patient quality of life and reduces costs for healthcare providers.
Brands: HemoScreen™